EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?

    loading  Checking for direct PDF access through Ovid

Abstract

Patients with inflammatory bowel disease who do not respond to steroid therapy often require treatment with immunomodulators in an attempt to achieve a response and maintain remission. However, a major concern and controversy is whether these treatments are putting the patients at a significantly increased risk of developing lymphomas. This case reports a patient with severe ulcerative colitis who had been previously treated with azathioprine and infliximab, and subsequently developed diffuse large B-cell colonic lymphoma.

Related Topics

    loading  Loading Related Articles